Skip to main content

Table 3 Ongoing phase 3 studies of newer radiosensitizers

From: Radiosensitizers in cervical cancer. Cisplatin and beyond

Arms # Pat Radiation
CDDP 40 mg/m2 250 EBRT 50.4 + brachyterapy
Vs   
CDDP 40 mg/m2+ Gemcitabine 125 mg/m2 + Two post-brachy 21-day adjuvant courses CDDP 75 mg/m2/d1 plus Gemcitabine 1 gr/m2 d1&d8 250 EBRT 50.4 + brachyterapy
CDDP 40 mg/m2+ Gemcitabine 125 mg/m2 180 EBRT 50 Gy in 2 Gy fractions+ Brachytherapy
Vs   
CDDP 40 mg/m2+ Gemcitabine 125 mg/m2 180 EBRT 50 Gy in 2 Gy fractions+ Radical hysterectomy